Latest News & Features
Patents
In an incredibly competitive and complex landscape, intellectual property is a critical asset for pharmaceutical and biotech companies. 29 October 2024
Patents
Machine learning can be an invaluable tool in drug discovery for target identification, compound screening, and predictive modeling. The use of AI can accelerate drug discovery timelines, reduce costs and enhance therapeutic outcomes. 29 October 2024
Patents
In today's global marketplace, intellectual property (IP) rights are not merely legal tools but strategic assets that can significantly influence a product's lifecycle, from development to market. 29 October 2024
Patents
As part of a lifecycle IP strategy for a therapeutic product, it can be important to protect inventions arising during the clinical development of the product. 29 October 2024
Patents
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step. 29 October 2024
Copyright
A court’s decision in favour of a software company is set to have a ripple effect on cases relating to fair use and artificial intelligence. Marisa Woutersen spoke to the winning counsel to find out more. 29 October 2024
Unified Patent Court
German company files suit against chipmaker at the UPC in Munich | Case marks chipmaker’s first major dispute at the pan-European court | Suit follows Nvidia’s emergence as the world’s most valuable company and Microsoft dispute in the US. 29 October 2024
Patents
Agreement halts all litigation in multiple jurisdictions between the pair | US company agrees to pay royalties to the Finnish telecoms giant for using video technology in its devices. 29 October 2024
Copyright
Member states cannot apply material reciprocity clause in Berne Convention following judgment | Decision relates to dispute over iconic Eames-designed chair 28 October 2024
Patents
A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an award of just $250 for the tech giant | Despite the victory, Masimo says the ruling does not apply to its current products. 28 October 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.